(Q52895583)

9 May 2018

title

Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity. (English)

1 reference

9 May 2018

1 reference

Lee TC

1

1 reference

9 May 2018

Charles B

2

1 reference

9 May 2018

Steer P

3

1 reference

9 May 2018

Flenady V

4

1 reference

9 May 2018

Shearman A

5

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 June 1997

1 reference

9 May 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

9 May 2018

volume

61

1 reference

9 May 2018

issue

6

1 reference

9 May 2018

page(s)

628-640

1 reference

9 May 2018

Pharmacokinetic profile of caffeine in the premature newborn infant with apnea

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Caffeine metabolism in the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Epidemiology and pathophysiology of apnoea of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Comparative evaluation of caffeine and theophylline for weaning premature infants from the ventilator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Caffeine or theophylline for neonatal apnoea?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Efficacy of caffeine in treatment of apnea in the low-birth-weight infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Use of caffeine in infants unresponsive to theophylline in apnea of prematurity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Population pharmacokinetics of caffeine in neonates and young infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Some suggestions for measuring predictive performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Theophylline population pharmacokinetics from routine monitoring data in very premature infants with apnoea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Does caffeine prevent hypoxaemic episodes in premature infants? A randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Pharmacokinetic aspects of caffeine in premature infants with apnoea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Maturation of caffeine elimination in infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Methylxanthines: toxicity to humans. 2. Caffeine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Metabolism of theophylline to caffeine in premature newborn infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Caffeine disposition after oral doses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Pharmacokinetics of intravenous caffeine: comparison of high-performance liquid chromatographic and gas chromatographic methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Dose-dependent pharmacokinetics of caffeine in humans: relevance as a test of quantitative liver function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Dose-dependency of caffeine metabolism with repeated dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

Protein binding of caffeine in young and elderly males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990097-7

10.1016/S0009-9236(97)90097-7

7 January 2021

Identifiers

DOI

1 reference

9 May 2018

PubMed ID

9209245

1 reference

9 May 2018